Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Brereton (Southampton, United Kingdom), L. Yao (Southampton, United Kingdom), J. Bell (Southampton, United Kingdom), F. Conforti (Southampton, United Kingdom), A. Alzetani (Southampton, United Kingdom), A. Fabre (Dublin , Ireland), B. Marshall (Southampton, United Kingdom), L. Richeldi (Rome, Italy), D. Davies (Southampton, United Kingdom), Y. Wang (Southampton, United Kingdom), M. Jones (Southampton, United Kingdom). Hypoxia-inducible factor pathway activation promotes bone-type collagen cross-linking in Idiopathic Pulmonary Fibrosis. 2424

Member's Comments

No comment yet.

Related content which might interest you: Nuclear miRNA/exosome-mediated transcriptional silencing within the context of TGFB1 signaling and Idiopathic Pulmonary Fibrosis. Source: International Congress 2017 – Interstitial lung diseases (ILDs): novel pathogenetic pathways Year: 2017 mTOR signalling is an essential pathway for TGF-β1 induced collagen synthesis Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Mesenchyme associated transcription factor PRRX1: A key regulator of IPF fibroblast Source: International Congress 2016 – Repair pathways: from lung development to ageing of the lung Year: 2016 Modulation of fibroblast phenotype in idiopathic pulmonary fibrosis: Role of Nrf2 Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases Year: 2011 KCa3.1 mediates alphaSMA expression in human lung myofibroblast via the Smad2/3 and TGFbeta1 signalling pathway Source: International Congress 2014 – Cell biology 2014 Year: 2014 Epidermal growth factor receptor (EGFR) activation is required for TGFbeta1-induced epithelial-mesenchymal transition (EMT) in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Oral presentation: Protease-activated receptor-2 plays a pivotal role in pulmonary fibrosis by inducing myofibroblast differentiation and tissue factor up-regulation Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung Year: 2010 Metformin inhibits TGF-b-induced myofibroblast differentiation through AMPK activation Source: International Congress 2014 – Cell biology 2014 Year: 2014 Fibroblast growth factor 9 (FGF9) modulates the phenotype of control and fibrotic human lung fibroblasts in vitro Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 Airway epithelial cell IP-10 production is regulated by miR-31 via the transcription factor IRF-1 Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 Expression of Smad proteins during myofibroblast differentiation in pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 267s Year: 2005 BIBF1120 inhibits fibroblasts proliferation and production of the extracellular matrix protein fibulin-1 Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Idiopathic pulmonary fibrosis in relation to the gene polymorphisms of transforming growth factor-beta1 and plasminogen activation inhibitor 1 Source: Eur Respir J 2007; 30: Suppl. 51, 489s Year: 2007 SRC family kinase inhibition reduces NOX4 expression in bronchial epithelial cells from Idiopathic Pulmonary Fibrosis patients Source: International Congress 2019 – Damage and remodelling in pulmonary fibrosis Year: 2019 Inhibition of VEGF blocks TGF-β1 production through a PI3K/Akt signalling pathway Source: Eur Respir J 2008; 31: 523-531 Year: 2008 LSC 2010 Abstract: Protease-activated receptor-2 plays a pivotal role in pulmonary fibrosis by inducing myofibroblast differentiation and tissue factor up-regulation Source: Annual Congress 2010 - Stem cells and growth factors in lung injury Year: 2010 Pleural fibrosis induced by transforming growth factor (TGF)-β1 gene transfer Source: Eur Respir J 2005; 26: Suppl. 49, 100s Year: 2005 MMP-12 activates protease activated receptor (PAR)-1, upregulates placenta growth factor and leads to pulmonary emphysema Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium Year: 2018 Altered protein homeostasis in pulmonary fibrosis indicates a role for proteasomal activator 200 Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 Low density lipoprotein receptor-related protein 1 is a novel activator of beta1 Integrin-dependent fibroblast adhesion, spreading and migration Source: International Congress 2014 – ILDs 1 Year: 2014